Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin

Head and neck squamous carcinoma (HNSCC) is the seventh most common cancer worldwide. Targeted therapeutic drugs for HNSCC are still being explored. Among them, (S)-10-hydroxycamptothecin (10-HCPT), a specific inhibitor of TOP1, functions by DNA double-strand breaks that can inhibit DNA replication...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Shanshan, Lin, Chen, Li, Yanguo, Wei, Zhengyu, cao, Bing, Shen, Zhisen, Deng, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492332/
https://www.ncbi.nlm.nih.gov/pubmed/37689760
http://dx.doi.org/10.1186/s40001-023-01289-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492332/
https://www.ncbi.nlm.nih.gov/pubmed/37689760
http://dx.doi.org/10.1186/s40001-023-01289-y

Ejemplares similares